SE7909401L - Cefalosporinantibiotika - Google Patents

Cefalosporinantibiotika

Info

Publication number
SE7909401L
SE7909401L SE7909401A SE7909401A SE7909401L SE 7909401 L SE7909401 L SE 7909401L SE 7909401 A SE7909401 A SE 7909401A SE 7909401 A SE7909401 A SE 7909401A SE 7909401 L SE7909401 L SE 7909401L
Authority
SE
Sweden
Prior art keywords
compounds
formula
methylpyrazolium
ceph
aminothiazol
Prior art date
Application number
SE7909401A
Other languages
English (en)
Swedish (sv)
Inventor
C H O'callaghan
B E Ayres
C E Newall
D G H Livermore
D R Sutherland
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE7909401L publication Critical patent/SE7909401L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
SE7909401A 1978-11-15 1979-11-14 Cefalosporinantibiotika SE7909401L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7844595 1978-11-15
GB7844597 1978-11-15

Publications (1)

Publication Number Publication Date
SE7909401L true SE7909401L (sv) 1980-05-16

Family

ID=26269583

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7909401A SE7909401L (sv) 1978-11-15 1979-11-14 Cefalosporinantibiotika

Country Status (17)

Country Link
US (1) US4464368A (fr)
AT (1) AT366387B (fr)
AU (1) AU529825B2 (fr)
CA (1) CA1136616A (fr)
CH (1) CH647784A5 (fr)
DE (1) DE2946038A1 (fr)
DK (1) DK480679A (fr)
ES (3) ES485937A1 (fr)
FI (1) FI793566A (fr)
FR (1) FR2441630A1 (fr)
IE (1) IE49207B1 (fr)
IL (1) IL58717A (fr)
LU (1) LU81884A1 (fr)
NL (1) NL7908318A (fr)
NO (1) NO793688L (fr)
NZ (1) NZ192127A (fr)
SE (1) SE7909401L (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78245B (fr) * 1980-09-12 1984-09-26 Ciba Geigy Ag
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
ES8306160A1 (es) * 1981-04-03 1983-05-01 Fujisawa Pharmaceutical Co "procedimiento para preparar un nuevo compuesto de cefem".
DE3336757A1 (de) * 1983-10-08 1985-04-25 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
CN86107947A (zh) * 1985-11-22 1987-05-27 藤沢药品工业株式会社 新的头孢烯化合物及其制备方法
US5373000A (en) * 1985-12-26 1994-12-13 Eisai Co., Ltd. 7Beta-(thiadiazolyl)-2-iminoacetamido-3cephem compounds
EP0346465B1 (fr) * 1986-04-14 1993-08-11 Banyu Pharmaceutical Co., Ltd. Derives de 1-carboxy-1-vinyloxyiminoaminothiazole cephalosporine et leur procede de preparation
GB8611823D0 (en) * 1986-05-15 1986-06-25 Ici Plc Process
CA1293719C (fr) * 1986-09-22 1991-12-31 Takao Takaya Composes de cephem et procede de preparation
US5162520A (en) * 1986-09-22 1992-11-10 Fujisawa Pharmaceutical Co., Ltd. Intermediates for cephem compounds
US6407061B1 (en) 1989-12-05 2002-06-18 Chiron Corporation Method for administering insulin-like growth factor to the brain
US5624898A (en) 1989-12-05 1997-04-29 Ramsey Foundation Method for administering neurologic agents to the brain
US10000510B2 (en) 2014-08-18 2018-06-19 Merck Sharp & Dohme Corp. Salt forms of ceftolozane
US10214543B2 (en) 2014-12-30 2019-02-26 Merck Sharp & Dohme Corp. Synthesis of cephalosporin compounds

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US4024133A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-,furyl- or pyridylacetamido)]cephalosporins
US4064346A (en) * 1971-05-14 1977-12-20 Glaxo Laboratories Limited 3-Acetoxymethyl-7β-(2-carboxy-methoxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US4091209A (en) * 1971-05-14 1978-05-23 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl or naphthylacetamido)]cephalosporins having a 2-haloalkylcarbamoyloxymethyl group at the 3-position
US4024137A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins
US4017515A (en) * 1971-05-14 1977-04-12 Glaxo Laboratories Limited α-(Etherified oximino) carboxylic acids and acid chlorides
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
US4079178A (en) * 1971-05-14 1978-03-14 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino) acylamido groups at the 7-position
US4093803A (en) * 1971-05-14 1978-06-06 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins
US4095021A (en) * 1973-12-21 1978-06-13 Glaxo Laboratories Limited 3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof
US4162360A (en) * 1973-12-21 1979-07-24 Glaxo Laboratories Limited 3-Carbamoyloxymethyl-7-substituted oximino acetamido cephalosporanic acid derivatives
US4144392A (en) * 1973-12-21 1979-03-13 Glaxo Laboratories Limited Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
US4060686A (en) * 1973-12-21 1977-11-29 Janice Bradshaw Cephalosporins having a 7-(carboxy substituted α-etherified oximinoarylacetamido) group
GB1496757A (en) * 1973-12-21 1978-01-05 Glaxo Lab Ltd Cephalosporin derivatives
US4032950A (en) * 1974-12-06 1977-06-28 Hughes Aircraft Company Liquid phase epitaxial process for growing semi-insulating gaas layers
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4165430A (en) * 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
FR2457296A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
IL61458A0 (en) * 1979-12-07 1980-12-31 Erba Farmitalia N-substituted thiazolyl derivatives of oximino-substituted cephalosporins, their preparation and pharmalceutical compositions containing them
US4382932A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company Isoquinolinium substituted cephalosporins

Also Published As

Publication number Publication date
DK480679A (da) 1980-05-16
NZ192127A (en) 1982-12-21
CA1136616A (fr) 1982-11-30
LU81884A1 (fr) 1980-06-05
IE49207B1 (en) 1985-08-21
ES485937A1 (es) 1980-07-01
FR2441630B1 (fr) 1983-06-03
CH647784A5 (de) 1985-02-15
AT366387B (de) 1982-04-13
DE2946038A1 (de) 1980-05-29
AU5281579A (en) 1980-05-22
ES485938A1 (es) 1980-07-01
IE792186L (en) 1980-05-15
FI793566A (fi) 1980-05-16
ES485939A1 (es) 1980-07-01
US4464368A (en) 1984-08-07
IL58717A (en) 1983-05-15
IL58717A0 (en) 1980-02-29
FR2441630A1 (fr) 1980-06-13
AU529825B2 (en) 1983-06-23
NL7908318A (nl) 1980-05-19
NO793688L (no) 1980-05-19
ATA727279A (de) 1981-08-15

Similar Documents

Publication Publication Date Title
SE7904576L (sv) Cefalosporinantibiotika
SE7909401L (sv) Cefalosporinantibiotika
SE7904577L (sv) Cefalosporinantibiotika
SE8006861L (sv) Cefalosporinantibiotika
SE8006860L (sv) Cefalosporinantibiotika
SE8001423L (sv) Cefalosporinantibiotika
SE8002217L (sv) Cefalosporinantibiotika
ES485440A1 (es) Un procedimiento para la preparacion de antibioticos de ce- falosporina
SE7706081L (sv) Forfarande for framstellning av cefalosporiner
DE3476663D1 (en) Crystalline form of ceftazidim
JPS6485A (en) Novel cephalosporin derivative
DK481883A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
SE8008540L (sv) N-substituerade tiazolylderivat av oxi-imino-substituerade cefalosporiner och forfarande for framstellning derav
SE8303727L (sv) Cefalosporinantibiotika
SE8105628L (sv) Cefalosporinderivat

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7909401-7

Format of ref document f/p: F